Yadira X. Pérez-Páramo

Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions

Shamema Nasrin, Christy J.W. Watson, Yadira X. Pérez-Páramo et al. · Drug Metabolism and Disposition · 2021 · 149 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A New Gene Expression Signature for Triple-Negative Breast Cancer using Frozen Fresh Tissue before Neoadjuvant chemotherapy

Sandra K. Santuario-Facio, Servando Cardona‐Huerta, Yadira X. Pérez-Páramo et al. · Molecular Medicine · 2017 · 55 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Interethnic Variability in <i>CYP2D6</i> , <i>CYP2C9</i> , and <i>CYP2C19</i> Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics

María-Eugenia G. Naranjo, Fernanda Rodrigues‐Soares, Eva Peñas‐Lledó et al. · OMICS A Journal of Integrative Biology · 2018 · 49 citations · Full text

Medicine, Genetics, Pharmacology +17

Nicotine- <i>N</i> ′-Oxidation by Flavin Monooxygenase Enzymes

Yadira X. Pérez-Páramo, Gang Chen, Joseph H. Ashmore et al. · Cancer Epidemiology Biomarkers & Prevention · 2018 · 32 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers

Yadira X. Pérez-Páramo, Christy J.W. Watson, Gang Chen et al. · Cancer Epidemiology Biomarkers & Prevention · 2022 · 17 citations · Full text

Life Sciences, Genetics, Pharmacology +12